Documents

Discussions Technicals Forecast Seasonals

Dermapharm Holding SE documents

Explore the latest documents from Dermapharm Holding SE, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 26, 2025

Slides

Interim report

Q1 2025

May 15, 2025

Slides

Interim report

2024

Q4 2024

Mar 28, 2025

Slides

Annual report

Q3 2024

Nov 14, 2024

Interim report

Slides

Q2 2024

Aug 27, 2024

Slides

Interim report

Q1 2024

May 15, 2024

Interim report

Slides

2023

Q4 2023

Mar 28, 2024

Slides

Annual report

Q3 2023

Nov 15, 2023

Slides

Interim report

Q2 2023

Aug 29, 2023

Interim report

Slides

Q1 2023

May 15, 2023

Interim report

Slides

2022

Q4 2022

Mar 28, 2023

Slides

Annual report

Q3 2022

Nov 16, 2022

Slides

Interim report

Q2 2022

Sep 07, 2022

Slides

Interim report

Q1 2022

May 18, 2022

Slides

Interim report

2021

Q4 2021

Apr 14, 2022

Slides

Annual report